Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Uveal Neoplasms, breast disorder, breast neoplasm, cancer, digestive system disorder, digestive system neoplasm, eye disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, uveal disorder, uveal melanomaActive, not recruitingPhase 12026-02-27NCT04336241

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Replimune, Inc.14

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Churchill HospitalOxfordUnited Kingdom2
Hospital Clinico de ValenciaValenciaSpain14
Hospital Universitario d'HebronBarcelonaSpain1
Hospital Universitario HM SanchinarroMadridSpain1
The Clatterbridge Cancer Centre NHS Foundation TrustBebingtonUnited Kingdom2
The Royal Marsden NHS Foundation TrustLondonUnited Kingdom41